Kiniksa Pharmaceuticals International (KNSA) Other Gross PP&E Adjustments (2021 - 2025)
Historic Other Gross PP&E Adjustments for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to -$4.9 million.
- Kiniksa Pharmaceuticals International's Other Gross PP&E Adjustments rose 6738.23% to -$4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.9 million, marking a year-over-year increase of 6738.23%. This contributed to the annual value of -$5.1 million for FY2024, which is 7303.45% up from last year.
- Per Kiniksa Pharmaceuticals International's latest filing, its Other Gross PP&E Adjustments stood at -$4.9 million for Q3 2025, which was up 6738.23% from -$7.0 million recorded in Q2 2025.
- In the past 5 years, Kiniksa Pharmaceuticals International's Other Gross PP&E Adjustments ranged from a high of $1.8 million in Q2 2022 and a low of -$19.1 million during Q4 2023
- Its 5-year average for Other Gross PP&E Adjustments is -$6.1 million, with a median of -$6.3 million in 2021.
- As far as peak fluctuations go, Kiniksa Pharmaceuticals International's Other Gross PP&E Adjustments tumbled by 18685000.0% in 2022, and later soared by 9097.35% in 2023.
- Kiniksa Pharmaceuticals International's Other Gross PP&E Adjustments (Quarter) stood at -$6.3 million in 2021, then plummeted by 37.57% to -$8.7 million in 2022, then crashed by 120.1% to -$19.1 million in 2023, then skyrocketed by 73.03% to -$5.1 million in 2024, then grew by 4.5% to -$4.9 million in 2025.
- Its Other Gross PP&E Adjustments was -$4.9 million in Q3 2025, compared to -$7.0 million in Q2 2025 and -$6.2 million in Q1 2025.